BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Green KY. Norovirus infection in immunocompromised hosts. Clin Microbiol Infect 2014;20:717-23. [PMID: 25040790 DOI: 10.1111/1469-0691.12761] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Lei S, Ramesh A, Twitchell E, Wen K, Bui T, Weiss M, Yang X, Kocher J, Li G, Giri-Rachman E, Trang NV, Jiang X, Ryan EP, Yuan L. High Protective Efficacy of Probiotics and Rice Bran against Human Norovirus Infection and Diarrhea in Gnotobiotic Pigs. Front Microbiol 2016;7:1699. [PMID: 27853451 DOI: 10.3389/fmicb.2016.01699] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
2 Van Dycke J, Rymenants J, Neyts J, Rocha-Pereira J. Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Identification of active compounds. Antivir Chem Chemother 2021;29:20402066211026852. [PMID: 34187186 DOI: 10.1177/20402066211026852] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Korte S, Pettke A, Kossow A, Mellmann A, Willems S, Kipp F. Norovirus outbreak management: how much cohorting is necessary? Journal of Hospital Infection 2016;92:259-62. [DOI: 10.1016/j.jhin.2015.10.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Gupta N, Lainson JC, Belcher PE, Shen L, Mason HS, Johnston SA, Diehnelt CW. Cross-Reactive Synbody Affinity Ligands for Capturing Diverse Noroviruses. Anal Chem 2017;89:7174-81. [DOI: 10.1021/acs.analchem.7b01337] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ettayebi K, Crawford SE, Murakami K, Broughman JR, Karandikar U, Tenge VR, Neill FH, Blutt SE, Zeng XL, Qu L, Kou B, Opekun AR, Burrin D, Graham DY, Ramani S, Atmar RL, Estes MK. Replication of human noroviruses in stem cell-derived human enteroids. Science. 2016;353:1387-1393. [PMID: 27562956 DOI: 10.1126/science.aaf5211] [Cited by in Crossref: 717] [Cited by in F6Publishing: 649] [Article Influence: 119.5] [Reference Citation Analysis]
6 He T, McMillen TA, Qiu Y, Chen LH, Lu X, Pang XL, Kamboj M, Tang YW. Norovirus Loads in Stool Specimens of Cancer Patients with Norovirus Gastroenteritis. J Mol Diagn 2017;19:836-42. [PMID: 28807813 DOI: 10.1016/j.jmoldx.2017.06.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
7 Baldridge MT, Turula H, Wobus CE. Norovirus Regulation by Host and Microbe. Trends Mol Med. 2016;22:1047-1059. [PMID: 27887808 DOI: 10.1016/j.molmed.2016.10.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
8 . Anforderungen an die Infektionsprävention bei der medizinischen Versorgung von immunsupprimierten Patienten : Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021;64:232-64. [PMID: 33394069 DOI: 10.1007/s00103-020-03265-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 van Schewick CM, Nöltner C, Abel S, Burns SO, Workman S, Symes A, Guzman D, Proietti M, Bulashevska A, Moreira F, Soetedjo V, Lowe DM, Grimbacher B. Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea. Front Immunol 2020;11:1654. [PMID: 32849570 DOI: 10.3389/fimmu.2020.01654] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Rolfes MC, Sriaroon P, Dávila Saldaña BJ, Dvorak CC, Chapdelaine H, Ferdman RM, Chen K, Jolles S, Patel NC, Kim YJ, Tarrant TK, Martelius T, Seppanen M, Joshi AY. Chronic norovirus infection in primary immune deficiency disorders: an international case series. Diagn Microbiol Infect Dis 2019;93:69-73. [PMID: 30174143 DOI: 10.1016/j.diagmicrobio.2018.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Woodward J, Gkrania-Klotsas E, Kumararatne D. Chronic norovirus infection and common variable immunodeficiency. Clin Exp Immunol. 2017;188:363-370. [PMID: 27753065 DOI: 10.1111/cei.12884] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 6.7] [Reference Citation Analysis]
12 Karst SM, Tibbetts SA. Recent advances in understanding norovirus pathogenesis. J Med Virol 2016;88:1837-43. [PMID: 27110852 DOI: 10.1002/jmv.24559] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
13 Ariza-Heredia EJ, Chemaly RF. Update on infection control practices in cancer hospitals. CA Cancer J Clin 2018;68:340-55. [PMID: 29985544 DOI: 10.3322/caac.21462] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
14 Platts-Mills JA, Taniuchi M, Uddin MJ, Sobuz SU, Mahfuz M, Gaffar SA, Mondal D, Hossain MI, Islam MM, Ahmed AS, Petri WA, Haque R, Houpt ER, Ahmed T. Association between enteropathogens and malnutrition in children aged 6-23 mo in Bangladesh: a case-control study. Am J Clin Nutr 2017;105:1132-8. [PMID: 28381477 DOI: 10.3945/ajcn.116.138800] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
15 Broglie JJ, Alston B, Yang C, Ma L, Adcock AF, Chen W, Yang L. Antiviral Activity of Gold/Copper Sulfide Core/Shell Nanoparticles against Human Norovirus Virus-Like Particles. PLoS One 2015;10:e0141050. [PMID: 26474396 DOI: 10.1371/journal.pone.0141050] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 6.1] [Reference Citation Analysis]
16 Zhu S, Watanabe M, Kirkpatrick E, Murray AB, Sok R, Karst SM. Regulation of Norovirus Virulence by the VP1 Protruding Domain Correlates with B Cell Infection Efficiency. J Virol 2015;90:2858-67. [PMID: 26719276 DOI: 10.1128/JVI.02880-15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
17 Makimaa H, Ingle H, Baldridge MT. Enteric Viral Co-Infections: Pathogenesis and Perspective. Viruses 2020;12:E904. [PMID: 32824880 DOI: 10.3390/v12080904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Thorne L, Goodfellow I. Reply to Kempf et al. J Infect Dis 2017;215:487-8. [PMID: 28362906 DOI: 10.1093/infdis/jiw498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
19 Alby K, Nachamkin I, Hayden RT, Wolk DM, Carroll KC, Tang Y. Gastrointestinal Infections. Microbiol Spectr 2016;4. [DOI: 10.1128/microbiolspec.dmih2-0005-2015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Bruggink LD, Hayes L, Marshall JA. Chronic norovirus infection in a patient with a past history of Burkitt lymphoma. Virusdisease 2015;26:207-10. [PMID: 26396990 DOI: 10.1007/s13337-015-0275-7] [Reference Citation Analysis]
21 Nasheri N, Petronella N, Ronholm J, Bidawid S, Corneau N. Characterization of the Genomic Diversity of Norovirus in Linked Patients Using a Metagenomic Deep Sequencing Approach. Front Microbiol 2017;8:73. [PMID: 28197136 DOI: 10.3389/fmicb.2017.00073] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
22 Branch-Elliman W, Araujo-Castillo RV, Snyder GM, Sullivan BF, Alonso CD, Wright SB. Identification of a norovirus outbreak on a hematopoietic stem cell transplant unit and development and implementation of a novel infection prevention algorithm for controlling transmission. Infect Control Hosp Epidemiol 2020;41:472-6. [PMID: 32091351 DOI: 10.1017/ice.2020.21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Hofmann FM, Michaelis M, Stößel U, Hofmann F. [On Statistical Underreporting of Norovirus-Infections: Insights from Register Data of Two Local Public Health Authorities]. Gesundheitswesen 2021;83:357-62. [PMID: 31962363 DOI: 10.1055/a-1076-8128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Newman KL, Moe CL, Kirby AE, Flanders WD, Parkos CA, Leon JS. Norovirus in symptomatic and asymptomatic individuals: cytokines and viral shedding. Clin Exp Immunol 2016;184:347-57. [PMID: 26822517 DOI: 10.1111/cei.12772] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
25 Parra GI, Squires RB, Karangwa CK, Johnson JA, Lepore CJ, Sosnovtsev SV, Green KY. Static and Evolving Norovirus Genotypes: Implications for Epidemiology and Immunity. PLoS Pathog 2017;13:e1006136. [PMID: 28103318 DOI: 10.1371/journal.ppat.1006136] [Cited by in Crossref: 134] [Cited by in F6Publishing: 121] [Article Influence: 26.8] [Reference Citation Analysis]
26 Kreidieh K, Charide R, Dbaibo G, Melhem NM. The epidemiology of Norovirus in the Middle East and North Africa (MENA) region: a systematic review. Virol J 2017;14:220. [PMID: 29126448 DOI: 10.1186/s12985-017-0877-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
27 Chéron N, Yu C, Kolawole AO, Shakhnovich EI, Wobus CE. Repurposing of rutin for the inhibition of norovirus replication. Arch Virol 2015;160:2353-8. [PMID: 26112762 DOI: 10.1007/s00705-015-2495-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
28 Roth AN, Karst SM. Norovirus mechanisms of immune antagonism. Curr Opin Virol 2016;16:24-30. [PMID: 26673810 DOI: 10.1016/j.coviro.2015.11.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
29 Lee S, Baldridge MT. Interferon-Lambda: A Potent Regulator of Intestinal Viral Infections. Front Immunol 2017;8:749. [PMID: 28713375 DOI: 10.3389/fimmu.2017.00749] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
30 Bok K, Prevots DR, Binder AM, Parra GI, Strollo S, Fahle GA, Behrle-Yardley A, Johnson JA, Levenson EA, Sosnovtsev SV, Holland SM, Palmore TN, Green KY. Epidemiology of Norovirus Infection Among Immunocompromised Patients at a Tertiary Care Research Hospital, 2010-2013. Open Forum Infect Dis 2016;3:ofw169. [PMID: 27800529 DOI: 10.1093/ofid/ofw169] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
31 Brown JR, Gilmour K, Breuer J. Norovirus Infections Occur in B-Cell-Deficient Patients. Clin Infect Dis 2016;62:1136-8. [PMID: 26908782 DOI: 10.1093/cid/ciw060] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
32 Li Y, Handley SA, Baldridge MT. The dark side of the gut: Virome-host interactions in intestinal homeostasis and disease. J Exp Med 2021;218:e20201044. [PMID: 33760921 DOI: 10.1084/jem.20201044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Hartono S, Bhagia A, Joshi AY. No! When the immunologist becomes a virologist: Norovirus – an emerging infection in immune deficiency diseases. Current Opinion in Allergy & Clinical Immunology 2016;16:557-64. [DOI: 10.1097/aci.0000000000000323] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Chong PP, Atmar RL. Norovirus in health care and implications for the immunocompromised host. Curr Opin Infect Dis 2019;32:348-55. [PMID: 31107251 DOI: 10.1097/QCO.0000000000000557] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
35 Mans J. Norovirus Infections and Disease in Lower-MiddleandLow-Income Countries, 1997⁻2018. Viruses 2019;11:E341. [PMID: 30974898 DOI: 10.3390/v11040341] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
36 da Silva Poló T, Peiró JR, Mendes LCN, Ludwig LF, de Oliveira-filho EF, Bucardo F, Huynen P, Melin P, Thiry E, Mauroy A. Human norovirus infection in Latin America. Journal of Clinical Virology 2016;78:111-9. [DOI: 10.1016/j.jcv.2016.03.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
37 Green KY. Editorial Commentary: Noroviruses and B Cells. Clin Infect Dis 2016;62:1139-40. [PMID: 26908783 DOI: 10.1093/cid/ciw063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
38 Hassan E, Baldridge MT. Norovirus encounters in the gut: multifaceted interactions and disease outcomes. Mucosal Immunol 2019;12:1259-67. [PMID: 31501514 DOI: 10.1038/s41385-019-0199-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
39 Parker JSL. A pLOT of Viral Persistence. Cell Host Microbe 2018;24:618-9. [PMID: 30439337 DOI: 10.1016/j.chom.2018.10.010] [Reference Citation Analysis]
40 Santos-Ferreira N, Van Dycke J, Neyts J, Rocha-Pereira J. Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections. Microorganisms 2021;9:1599. [PMID: 34442677 DOI: 10.3390/microorganisms9081599] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Ludwig-Begall LF, Mauroy A, Thiry E. Noroviruses-The State of the Art, Nearly Fifty Years after Their Initial Discovery. Viruses 2021;13:1541. [PMID: 34452406 DOI: 10.3390/v13081541] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 de Graaf M, van Beek J, Koopmans MPG. Human norovirus transmission and evolution in a changing world. Nat Rev Microbiol 2016;14:421-33. [DOI: 10.1038/nrmicro.2016.48] [Cited by in Crossref: 174] [Cited by in F6Publishing: 157] [Article Influence: 29.0] [Reference Citation Analysis]
43 Davis A, Cortez V, Grodzki M, Dallas R, Ferrolino J, Freiden P, Maron G, Hakim H, Hayden RT, Tang L, Huys A, Kolawole AO, Wobus CE, Jones MK, Karst SM, Schultz-Cherry S. Infectious Norovirus Is Chronically Shed by Immunocompromised Pediatric Hosts. Viruses 2020;12:E619. [PMID: 32516960 DOI: 10.3390/v12060619] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
44 Ruffner MA, Sullivan KE, Henrickson SE. Recurrent and Sustained Viral Infections in Primary Immunodeficiencies. Front Immunol 2017;8:665. [PMID: 28674531 DOI: 10.3389/fimmu.2017.00665] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
45 Brown JR, Roy S, Tutill H, Williams R, Breuer J. Super-infections and relapses occur in chronic norovirus infections. J Clin Virol 2017;96:44-8. [PMID: 28950185 DOI: 10.1016/j.jcv.2017.09.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
46 Karandikar UC, Crawford SE, Ajami NJ, Murakami K, Kou B, Ettayebi K, Papanicolaou GA, Jongwutiwes U, Perales MA, Shia J, Mercer D, Finegold MJ, Vinjé J, Atmar RL, Estes MK. Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients. J Gen Virol 2016;97:2291-300. [PMID: 27412790 DOI: 10.1099/jgv.0.000545] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 9.5] [Reference Citation Analysis]
47 Kim Y, Galasiti Kankanamalage AC, Chang KO, Groutas WC. Recent Advances in the Discovery of Norovirus Therapeutics. J Med Chem 2015;58:9438-50. [PMID: 26258852 DOI: 10.1021/acs.jmedchem.5b00762] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
48 Sacco KA, Pongdee T, Binnicker MJ, Espy M, Pardi D, Khanna S, Joshi AY. Presence of immune deficiency increases the risk of hospitalization in patients with norovirus infection. Diagn Microbiol Infect Dis 2018;90:300-6. [PMID: 29398461 DOI: 10.1016/j.diagmicrobio.2017.11.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
49 Degiuseppe JI, Barclay L, Gomes KA, Costantini V, Vinjé J, Stupka JA. Molecular epidemiology of norovirus outbreaks in Argentina, 2013-2018. J Med Virol 2020;92:1330-3. [PMID: 31981229 DOI: 10.1002/jmv.25684] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
50 Parra GI. Emergence of norovirus strains: A tale of two genes. Virus Evol 2019;5:vez048. [PMID: 32161666 DOI: 10.1093/ve/vez048] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
51 Brown LK, Clark I, Brown JR, Breuer J, Lowe DM. Norovirus infection in primary immune deficiency. Rev Med Virol 2017;27:e1926. [DOI: 10.1002/rmv.1926] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
52 Lei S, Ryu J, Wen K, Twitchell E, Bui T, Ramesh A, Weiss M, Li G, Samuel H, Clark-Deener S, Jiang X, Lee K, Yuan L. Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency. Sci Rep 2016;6:25222. [PMID: 27118081 DOI: 10.1038/srep25222] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
53 Brown JR, Roy S, Shah D, Williams CA, Williams R, Dunn H, Hartley J, Harris K, Breuer J. Norovirus Transmission Dynamics in a Pediatric Hospital Using Full Genome Sequences. Clin Infect Dis 2019;68:222-8. [PMID: 29800111 DOI: 10.1093/cid/ciy438] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
54 Kolawole AO, Smith HQ, Svoboda SA, Lewis MS, Sherman MB, Lynch GC, Pettitt BM, Smith TJ, Wobus CE. Norovirus Escape from Broadly Neutralizing Antibodies Is Limited to Allostery-Like Mechanisms. mSphere 2017;2:e00334-17. [PMID: 29062895 DOI: 10.1128/mSphere.00334-17] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
55 Lund BM. Provision of microbiologically safe food for vulnerable people in hospitals, care homes and in the community. Food Control 2019;96:535-47. [DOI: 10.1016/j.foodcont.2018.09.032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lin SC, Qu L, Ettayebi K, Crawford SE, Blutt SE, Robertson MJ, Zeng XL, Tenge VR, Ayyar BV, Karandikar UC, Yu X, Coarfa C, Atmar RL, Ramani S, Estes MK. Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids. Proc Natl Acad Sci U S A 2020;117:23782-93. [PMID: 32907944 DOI: 10.1073/pnas.2010834117] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
57 Kumthip K, Khamrin P, Ushijima H, Maneekarn N. Molecular detection and characterization of norovirus in asymptomatic food handlers in Chiang Mai, Thailand. Infect Genet Evol 2021;89:104725. [PMID: 33465494 DOI: 10.1016/j.meegid.2021.104725] [Reference Citation Analysis]
58 Steyer A, Konte T, Sagadin M, Kolenc M, Škoberne A, Germ J, Dovč-Drnovšek T, Arnol M, Poljšak-Prijatelj M. Intrahost Norovirus Evolution in Chronic Infection Over 5 Years of Shedding in a Kidney Transplant Recipient. Front Microbiol 2018;9:371. [PMID: 29552005 DOI: 10.3389/fmicb.2018.00371] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
59 Van Dycke J, Neyts J, Rocha-Pereira J. Assessing the Efficacy of Small Molecule Inhibitors in aMouse Model of Persistent Norovirus Infection. Bio Protoc 2018;8:e2831. [PMID: 34286040 DOI: 10.21769/BioProtoc.2831] [Reference Citation Analysis]
60 Hanajiri R, Sani GM, Saunders D, Hanley PJ, Chopra A, Mallal SA, Sosnovtsev SV, Cohen JI, Green KY, Bollard CM, Keller MD. Generation of Norovirus-Specific T Cells From Human Donors With Extensive Cross-Reactivity to Variant Sequences: Implications for Immunotherapy. J Infect Dis 2020;221:578-88. [PMID: 31562500 DOI: 10.1093/infdis/jiz491] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
61 Karst SM, Zhu S, Goodfellow IG. The molecular pathology of noroviruses. J Pathol 2015;235:206-16. [PMID: 25312350 DOI: 10.1002/path.4463] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
62 Pothier P, Kaiser L. Norovirus disease today. Clinical Microbiology and Infection 2014;20:716. [DOI: 10.1111/1469-0691.12760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]